# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-096780
Filing Date
2024-11-12
Accepted
2024-11-12 16:05:22
Documents
5
Period of Report
2024-12-22

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | ea0220766-def14a_chinapharma.htm | DEF 14A | 233833
2 | GRAPHIC | proxy_001.jpg | GRAPHIC | 774361
3 | GRAPHIC | proxy_002.jpg | GRAPHIC | 170662
4 | GRAPHIC | proxy_003.jpg | GRAPHIC | 369511
5 | GRAPHIC | proxy_004.jpg | GRAPHIC | 555768
| Complete submission text file | 0001213900-24-096780.txt |  | 2810981

Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34471 | Film No.: 241447958
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)